324 related articles for article (PubMed ID: 19443277)
1. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Tang SC; Lai KN
Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Guo H; Lai KN
Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
[TBL] [Abstract][Full Text] [Related]
3. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
Lai KN; Chan LY; Guo H; Tang SC; Leung JC
Pediatr Nephrol; 2011 Feb; 26(2):257-66. PubMed ID: 21125406
[TBL] [Abstract][Full Text] [Related]
5. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.
Tang SC; Leung JC; Chan LY; Tsang AW; Lai KN
J Am Soc Nephrol; 2006 Jun; 17(6):1633-43. PubMed ID: 16687627
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure.
Chan LY; Leung JC; Lai KN
Clin Exp Nephrol; 2004 Dec; 8(4):297-303. PubMed ID: 15619027
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
11. Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-kappaB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol.
Moon Y; Yang H; Park SH
Toxicol Appl Pharmacol; 2008 Aug; 231(1):94-102. PubMed ID: 18485432
[TBL] [Abstract][Full Text] [Related]
12. In vitro enhanced chemotaxis of CD25+ mononuclear cells in patients with familial IgAN through glomerulotubular interactions.
Tam KY; Leung JC; Chan LY; Lam MF; Tang SC; Lai KN
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F359-68. PubMed ID: 20484297
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
15. A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells.
Yao Q; Ayala ER; Qian JQ; Stenvinkel P; Axelsson J; Lindholm B
Clin Nephrol; 2007 Nov; 68(5):295-301. PubMed ID: 18044261
[TBL] [Abstract][Full Text] [Related]
16. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.
Lai KN; Chan LY; Tang SC; Tsang AW; Li FF; Lam MF; Lui SL; Leung JC
Kidney Int; 2004 Oct; 66(4):1403-16. PubMed ID: 15458433
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.
Leung JC; Chan LY; Tang SC; Lam MF; Chow CW; Lim AI; Lai KN
J Transl Med; 2011 Oct; 9():169. PubMed ID: 21974877
[TBL] [Abstract][Full Text] [Related]
18. Involvement of redox-sensitive extracellular-regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2009 May; 329(2):450-8. PubMed ID: 19211919
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
20. Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages.
An J; Nakajima T; Kuba K; Kimura A
Hypertens Res; 2010 Aug; 33(8):831-5. PubMed ID: 20505677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
